Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
1,349
Views
14
CrossRef citations to date
0
Altmetric
Research Paper

Inhibition of MicroRNA miR-101-3p on prostate cancer progression by regulating Cullin 4B (CUL4B) and PI3K/AKT/mTOR signaling pathways

Zhenhua Gua Department of Urology, Wuxi Traditional Chinese Medicine Hospital, Wuxi, China
,
Zhixin Youb Department of Urology, Kunshan Second People's Hospital, Kunshan City, China
,
Yucheng Yanga Department of Urology, Wuxi Traditional Chinese Medicine Hospital, Wuxi, China
,
Rui Dinga Department of Urology, Wuxi Traditional Chinese Medicine Hospital, Wuxi, China
,
Meili Wanga Department of Urology, Wuxi Traditional Chinese Medicine Hospital, Wuxi, China
,
Jianming Puc Department of Urology, Changshu Hospital Affiliated to Nanjing University of Chinese Medicine, Changshu, China
&
Jian Chena Department of Urology, Wuxi Traditional Chinese Medicine Hospital, Wuxi, ChinaCorrespondence[email protected]
 show all
Pages 4719-4735 | Received 15 Mar 2021, Accepted 24 Jun 2021, Published online: 01 Aug 2021

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394.
  • Patel SA, Vanharanta S. Epigenetic determinants of metastasis. Mol Oncol. 2017;11:79.
  • Gasnier A, Parvizi N. Updates on the diagnosis and treatment of prostate cancer. Br J Radiol. 2017;90:20170180.
  • Barry MJ, Simmons LH. Prevention of prostate cancer morbidity and mortality: primary prevention and early detection. Med Clin North Am. 2017;101:787.
  • Dall’Era MA, Cooperberg MR, Chan JM. Active surveillance for early-stage prostate cancer: review of the current literature. Cancer. 2008;112:1650.
  • Pishgar F, Ebrahimi H, Moghaddam SS, et al. Global, regional and national burden of prostate cancer, 1990 to 2015: results from the global burden of disease study 2015. J Urol. 2018;199:1224.
  • Huang L, Chaoquan H, Cao H, et al. MicroRNA-29c increases the chemosensitivity of pancreatic cancer cells by inhibiting USP22 mediated autophagy. Cell Physiol Biochem. 2018;47:747–758.
  • Takayama K-I, Misawa A, Inoue S. Significance of microRNAs in androgen signaling and prostate cancer progression. Cancers (Basel). 2017;9(8):102.
  • Jin Q, He W, Chen L, et al. MicroRNA-101-3p inhibits proliferation in retinoblastoma cells by targeting EZH2 and HDAC9. Exp Ther Med. 2018 Sep;16(3):1663–1670.
  • Li B, Xie D, Zhang H. MicroRNA-101-3p advances cisplatin sensitivity in bladder urothelial carcinoma through targeted silencing EZH2. J Cancer. 2019;10:12.
  • Li L, Shao MY, Zou SC, et al. MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44. J Neurooncol. 2019;141(1). DOI:10.1007/s11060-018-2973-7
  • Jackson S, Xiong Y. CRL4s: the CUL4-RING E3 ubiquitin ligases. Trends Biochem Sci. 2009;34:562.
  • Vulto-van Silfhout AT, Nakagawa T, Bahi-Buisson N. Variants in CUL4B are associated with cerebral malformations. Hum Mutat. 2015;36:106.
  • Miao C, Chang J, Zhang G. CUL4B promotes the pathology of adjuvant-induced arthritis in rats through the canonical Wnt signaling. J Mol Med (Berl). 2018;96:495.
  • Fang ZZ, Wang M, Yuan Y, et al. miR-381 and miR-489 suppress cell proliferation and invasion by targeting CUL4B via the Wnt/betacatenin pathway in gastric cancer. Int J Oncol. 2019;54:733.
  • Wang X, Chen Z. Knockdown of CUL4B suppresses the proliferation and invasion in non-small cell lung cancer cells. Oncol Res. 2016;24: 271.
  • Qi MH, Cui J, Jiao Y, et al. CUL4B promotes prostate cancer progression by forming positive feedback loop with SOX4. Oncogenesis. 2019;8:23.
  • Chen Z, Shen B-L, Qing-Ge F, et al. CUL4B promotes proliferation and inhibits apoptosis of human osteosarcoma cells. Oncol Rep. 2014;32:2047.
  • Alzahrani AS. PI3K/Akt/mTOR inhibitors in cancer: at the bench and bedside. Semin Cancer Biol. 2019 Dec 59:125–132.
  • Abdelrahman AE, Arafa SA, Ahmed RA. Prognostic value of Twist-1, E-cadherin and EZH2 in prostate cancer: an immunohistochemical study. Turk Patoloji Dergisi, 2017;33(3)
  • Jin M, Zhang T, Liu C, et al. miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells. Cancer Res. 2014;74:4183–4195.
  • Jin M, Zhang T, Liu C, et al. MiRNA 26a expression in a novel panel of African American prostate cancer cell lines. Ethn Dis. 2010;20:S1–96–100.
  • Ma T, Chen H, Wang P, et al. Downregulation of lncRNA ZEB1-AS1 represses cell proliferation, migration, and invasion through mediating PI3K/AKT/mTOR signaling by miR-342-3p/CUL4B axis in prostate cancer. Cancer Biother Radiopharm. 2020. DOI:10.1089/cbr.2019.3123
  • Chen G, Zhou H. MiRNA-708/CUL4B axis contributes into cell proliferation and apoptosis of osteosarcoma. Eur Rev Med Pharmacol Sci. 2018;22(17):5452–5459.
  • Zhang S, Ding L, Gao F, et al. Long non-coding RNA DSCAM-AS1 upregulates USP47 expression through sponging miR-101-3p to accelerate osteosarcoma progression[J]. Biochemistry and Cell Biology. 2020;98.
  • Song W, Song C, Chen Y, et al. Polysaccharide induced apoptosis in H22 cells through G2/M arrest and BCL2/BAX caspase-activated Fas pathway. Cell Mol Biol (Noisy-le-Grand). 2015;61(7):88–95.
  • Gao G, Dou QP. N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death. J Cell Biochem. 2000;80(1):53–72.
  • Freire R, Di Fagagna FD, Wu L, et al. Cleavage of the Bloom’s syndrome gene product during apoptosis by caspase-3 results in an impaired interaction with topoisomerase IIIalpha. Nucleic Acids Res. 2001;29(15):3172–3180.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.